https://www.haitiscienceandme.com/article/916263179-orion-pharma-announces-first-results-from-phase-1-2-teades-trial-with-tead-inhibitor-odm-212-in-patients-with-advanced-solid-tumours Haiti, Science, & Me en PressRelease 2026-05-30T18:30:00+00:00 Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.haitiscienceandme.com/article/916263193-orion-pharma-julkisti-ensimm-iset-tulokset-faasi-1-2-teades-tutkimuksesta-odm-212-molekyylill-tead-est-j-potilailla-joilla-on-kiinteit-kasvaimia Haiti, Science, & Me en PressRelease 2026-05-30T18:30:00+00:00 Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.haitiscienceandme.com/article/916263233-eikon-therapeutics-presents-data-on-clinical-stage-programs-at-the-2026-annual-meeting-of-the-american-society-of-clinical-oncology Haiti, Science, & Me en PressRelease 2026-05-30T18:30:00+00:00 Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology https://ml.globenewswire.com/media/02bfb0a7-27fe-4be6-b2f9-bc6eaf27b1d9/small/eikon-logo-jpg.jpg https://www.haitiscienceandme.com/article/916263197-globale-daten-der-rosetta-lung-02-studie-ermutigende-wirksamkeit-f-r-biontechs-und-bristol-myers-squibbs-bispezifischen Haiti, Science, & Me en PressRelease 2026-05-30T18:15:00+00:00 Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.haitiscienceandme.com/article/916263201-global-data-for-biontech-and-bristol-myers-squibb-s-pd-l1xvegf-a-bispecific-pumitamig-shows-encouraging-efficacy-in-patients-with-non-small-cell-lung Haiti, Science, & Me en PressRelease 2026-05-30T18:15:00+00:00 Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.haitiscienceandme.com/article/916253131-itm-announces-phase-3-compete-patient-reported-quality-of-life-data-with-n-c-a-lu-edotreotide-itm-11-vs-everolimus-at-asco-2026 Haiti, Science, & Me en PressRelease 2026-05-30T17:00:00+00:00 ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026 https://ml-eu.globenewswire.com/media/3411c2bd-01a5-4d06-ad90-4a6e168bad61/small/itm-logo-claim-rgb-high-res-png.png https://www.haitiscienceandme.com/article/916242825-mineralys-therapeutics-presents-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-in-participants-with-hypertension-and-chronic-kidney Haiti, Science, & Me en PressRelease 2026-05-30T15:15:00+00:00 Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026) https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.haitiscienceandme.com/article/916233170-vapofil-reviews-urgent-report-2026-the-shocking-vapofil-male-enhancement-supplement-trend-everyone-is-talking-about Haiti, Science, & Me en PressRelease 2026-05-30T14:27:03+00:00 Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About https://ml.globenewswire.com/media/ae83c67f-909d-4427-80c0-3bc4826dfd96/medium/vapofil.png https://www.haitiscienceandme.com/article/916233130-impact-biotech-presents-updated-data-from-phase-1-trial-of-padeliporfin-vtp-in-la-pdac-and-phase-3-enlighted-trial-in-lg-utuc-at-asco-2026 Haiti, Science, & Me en PressRelease 2026-05-30T14:00:00+00:00 ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026 https://ml-eu.globenewswire.com/media/68762066-1fff-4065-af45-d18da25273cd/small/impact-biotech-logo-final-resized-jpg.jpg https://www.haitiscienceandme.com/article/916233168-jelly-tide-urgent-report-2026-the-shocking-rise-of-jellytide-gummies-what-consumers-need-to-know-about-the-viral-wellness-trend Haiti, Science, & Me en PressRelease 2026-05-30T13:55:11+00:00 JELLY TIDE [URGENT REPORT 2026]: The Shocking Rise of JellyTide Gummies—What Consumers Need to Know About the Viral Wellness Trend https://ml.globenewswire.com/media/efdaec24-9315-43fe-a9b5-bd6e7ad6d1ee/medium/jelly-tide.png https://www.haitiscienceandme.com/article/916210640-immatics-presents-clinical-activity-of-ima203cd8-prame-cell-therapy-in-hard-to-treat-gynecologic-cancers-at-2026-asco-annual-meeting Haiti, Science, & Me en PressRelease 2026-05-30T12:00:00+00:00 Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.haitiscienceandme.com/article/916210703-cogent-biosciences-announces-detailed-clinical-data-from-peak-phase-3-trial-with-bezuclastinib-in-combination-with-sunitinib-in-gastrointestinal Haiti, Science, & Me en PressRelease 2026-05-30T12:00:00+00:00 Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/0bd526c3-2e64-4b0d-8de9-f7c2d662cb4c/medium/results-of-genotype-subgroup-analysis.png https://www.haitiscienceandme.com/article/916210716-replimune-presents-3-year-landmark-overall-survival-analysis-from-ignyte-clinical-trial-during-oral-presentation-at-the-2026-american-society-of Haiti, Science, & Me en PressRelease 2026-05-30T12:00:00+00:00 Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/YjE1MDE2MDctNGExMy00NmY3LWFkZjEtNjAyNTlhZDQ5MDMxLTExMjIxMDEtMjAyNi0wNS0zMC1lbg==/tiny/Replimune-Inc-.png https://www.haitiscienceandme.com/article/916198909-how-riccio-pharmacy-makes-online-medicine-delivery-easier-for-patients Haiti, Science, & Me en PressRelease 2026-05-30T10:00:01+00:00 How Riccio Pharmacy Makes Online Medicine Delivery Easier For Patients? https://ml.globenewswire.com/Resource/Download/eeffad72-6b60-45dd-8de4-6cd62e5bcbaa/image1.png https://www.haitiscienceandme.com/article/916121410-fobi-ai-provides-corporate-update-regarding-ffcto-revocation-process-and-q3-interim-filings Haiti, Science, & Me en PressRelease 2026-05-30T01:18:27+00:00 Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings https://ml.globenewswire.com/media/31962991-c527-4e55-ba5d-42ab8656de7f/small/logo-color-png.png https://www.haitiscienceandme.com/article/916104539-crypto-news-today-alphapepe-presale-stage-17-nears-sell-out-while-xrp-price-prediction-eyes-7-00 Haiti, Science, & Me en PressRelease 2026-05-30T00:00:00+00:00 Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00 https://ml.globenewswire.com/media/1fc58e52-07ff-49ab-906f-6192fb0edd0a/medium/alphapepe.jpg https://www.haitiscienceandme.com/article/916086633-cash-and-gift-cards-dominate-consumer-reward-preferences-kashkick-survey-of-224-000-aligns-with-507b-u-s-gift-card-market Haiti, Science, & Me en PressRelease 2026-05-29T21:32:00+00:00 Cash and Gift Cards Dominate Consumer Reward Preferences: Kashkick Survey of 224,000+ Aligns With $507B U.S. Gift Card Market https://pressranger.s3.us-west-1.amazonaws.com/3332470/free-uber-eats-gift-card-featured-image.jpg https://www.haitiscienceandme.com/article/916068921-celularity-receives-nasdaq-notice-regarding-form-10-q Haiti, Science, & Me en PressRelease 2026-05-29T21:15:00+00:00 Celularity Receives Nasdaq Notice Regarding Form 10-Q https://ml.globenewswire.com/media/ZGUzZjA0MjktZjQ4Zi00Yzk0LTllODYtMmU2MTQ5NWIxOTBjLTEyMTY1NjItMjAyNi0wNS0yOS1lbg==/tiny/Celularity-Inc-.png https://www.haitiscienceandme.com/article/916068876-kane-biotech-announces-grant-of-stock-options Haiti, Science, & Me en PressRelease 2026-05-29T21:05:00+00:00 Kane Biotech Announces Grant of Stock Options https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://www.haitiscienceandme.com/article/916068935-quest-pharmatech-provides-corporate-update-including-voluntary-adoption-of-csa-blanket-order-51-93-to-file-financial-statements-and-md-a-on Haiti, Science, & Me en PressRelease 2026-05-29T21:00:00+00:00 Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis https://ml.globenewswire.com/media/fd192331-1a31-44aa-b520-5409d720a0b6/small/questpt-logo-jpg.jpg https://www.haitiscienceandme.com/article/916068961-cloudastructure-receives-notice-from-nasdaq Haiti, Science, & Me en PressRelease 2026-05-29T20:45:00+00:00 Cloudastructure Receives Notice From Nasdaq https://ml.globenewswire.com/media/ZDE5YTg4M2YtODQ2Mi00MjkwLTlhNDItOTBjYmNiNDU3OThhLTEzMjMzNTMtMjAyNi0wNS0yOS1lbg==/tiny/CLOUDASTRUCTURE-INC-.png https://www.haitiscienceandme.com/article/916068767-latin-american-unit-of-top-ten-global-life-insurer-selects-salescloser-for-ai-driven-customer-engagement-and-onboarding Haiti, Science, & Me en PressRelease 2026-05-29T20:30:00+00:00 Latin American Unit of Top-Ten Global Life Insurer Selects SalesCloser for AI-Driven Customer Engagement and Onboarding https://ml-eu.globenewswire.com/media/108434c1-541f-4cd8-b1ed-78394968b9b1/small/screenshot-2026-03-31-at-21-32-17-png.png https://www.haitiscienceandme.com/article/916068932-crescent-biopharma-announces-grants-of-inducement-awards Haiti, Science, & Me en PressRelease 2026-05-29T20:15:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.haitiscienceandme.com/article/916068938-clip-money-inc-reports-first-quarter-2026-results Haiti, Science, & Me en PressRelease 2026-05-29T20:10:00+00:00 Clip Money Inc. Reports First Quarter 2026 Results https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png https://www.haitiscienceandme.com/article/916068942-jade-biosciences-to-host-conference-call-and-webcast-on-june-1-2026-at-8-00-a-m-et-to-discuss-interim-phase-1-healthy-volunteer-results-for Haiti, Science, & Me en PressRelease 2026-05-29T20:05:00+00:00 Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://www.haitiscienceandme.com/article/916068817-kiniksa-pharmaceuticals-to-present-at-upcoming-investor-conferences Haiti, Science, & Me en PressRelease 2026-05-29T20:01:00+00:00 Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences https://ml-eu.globenewswire.com/media/84055882-69ed-48db-be7d-99cc55be5ff3/small/image1-jpg.jpg https://www.haitiscienceandme.com/article/916068913-arvinas-to-present-at-jefferies-global-healthcare-conference Haiti, Science, & Me en PressRelease 2026-05-29T20:01:00+00:00 Arvinas to Present at Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.haitiscienceandme.com/article/916068812-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Haiti, Science, & Me en PressRelease 2026-05-29T20:00:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.haitiscienceandme.com/article/916051534-local-trade-copier-3-0-0-introduces-manual-like-trade-execution-and-advanced-trade-randomization-for-mt4-mt5 Haiti, Science, & Me en PressRelease 2026-05-29T19:32:07+00:00 Local Trade Copier 3.0.0 Introduces Manual-Like Trade Execution and Advanced Trade Randomization for MT4 & MT5 https://ml.globenewswire.com/Resource/Download/619eda36-4ebd-468f-8ea0-6197ed1e98db/screenshot-2026-05-29-143952.png https://www.haitiscienceandme.com/article/916051447-oculis-announces-topline-results-from-diamond-phase-3-trials-with-ocs-01-in-diabetic-macular-edema Haiti, Science, & Me en PressRelease 2026-05-29T19:05:50+00:00 Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.haitiscienceandme.com/article/916051484-epicooler-climatiseur-the-best-portable-ac-heater-for-any-room-no-installation-required Haiti, Science, & Me en PressRelease 2026-05-29T18:40:37+00:00 EpiCooler Climatiseur: The Best Portable AC & Heater for Any Room — No Installation Required https://ml.globenewswire.com/media/e983a52a-1dca-46c9-9a0b-0d8ef8951ea7/medium/epicooler.png https://www.haitiscienceandme.com/article/916020009-dr-matthew-t-provencher-receives-prestigious-2026-stephen-s-burkhart-shoulder-innovation-research-award Haiti, Science, & Me en PressRelease 2026-05-29T16:37:46+00:00 Dr. Matthew T. Provencher Receives Prestigious 2026 Stephen S. Burkhart Shoulder Innovation Research Award https://ml.globenewswire.com/media/ZDUzNzA2NjUtZDQzMC00YWEwLWFlMzUtNzU1OWQwMGMzZjkwLTExMzY3NDItMjAyNi0wNS0yOS1lbg==/tiny/The-Steadman-Clinic-and-Steadm.png https://www.haitiscienceandme.com/article/916019944-syncron-and-truecontext-help-manufacturers-turn-field-execution-into-better-warranty-decisions Haiti, Science, & Me en PressRelease 2026-05-29T15:38:06+00:00 Syncron and TrueContext Help Manufacturers Turn Field Execution into Better Warranty Decisions https://ml.globenewswire.com/media/037517a7-1137-4f2c-95cb-2f2eb086dba9/small/syncron-logo-no-tm-orange-1000px-png.png https://www.haitiscienceandme.com/article/916003223-adstra-earns-2026-great-place-to-work-certification-with-89-of-employees-confirming-it-s-a-great-place-to-work Haiti, Science, & Me en PressRelease 2026-05-29T15:30:12+00:00 Adstra Earns 2026 Great Place To Work Certification™, With 89% of Employees Confirming It's a Great Place to Work https://ml.globenewswire.com/media/5c2027c3-516d-4b9a-83fc-faa65cdac25f/small/untitled-design-2-png.png https://www.haitiscienceandme.com/article/916003170-aduro-clean-technologies-nimmt-im-juni-2026-an-branchen-und-investorenkonferenzen-teil Haiti, Science, & Me en PressRelease 2026-05-29T14:58:04+00:00 Aduro Clean Technologies nimmt im Juni 2026 an Branchen- und Investorenkonferenzen teil https://ml.globenewswire.com/media/64480e4b-abff-4eeb-8e76-2d847127fd05/small/aduro-full-logo-two-color-png.png https://www.haitiscienceandme.com/article/916003183-aduro-clean-technologies-participera-plusieurs-conf-rences-sectorielles-et-v-nements-destin-s-aux-investisseurs-en-juin-2026 Haiti, Science, & Me en PressRelease 2026-05-29T14:58:04+00:00 Aduro Clean Technologies participera à plusieurs conférences sectorielles et événements destinés aux investisseurs en juin 2026 https://ml.globenewswire.com/media/64480e4b-abff-4eeb-8e76-2d847127fd05/small/aduro-full-logo-two-color-png.png https://www.haitiscienceandme.com/article/916003166-dallas-federal-criminal-defense-attorney-john-helms-expands-digital-legal-resources-for-individuals-facing-federal-investigations Haiti, Science, & Me en PressRelease 2026-05-29T14:57:10+00:00 Dallas Federal Criminal Defense Attorney John Helms Expands Digital Legal Resources for Individuals Facing Federal Investigations https://ml.globenewswire.com/media/a4c0f968-134c-4a4d-9f77-5c55705b168c/medium/dallas-criminal-defense-attorney-john-helms-expands-digital.jpg https://www.haitiscienceandme.com/article/915987808-zenatech-buscar-nuevas-oportunidades-de-inversi-n-relacionadas-con-el-departamento-de-guerra-y-la-oficina-de-capital-estrat-gico-tras-los-informes-de Haiti, Science, & Me en PressRelease 2026-05-29T13:51:34+00:00 ZenaTech buscará nuevas oportunidades de inversión relacionadas con el Departamento de Guerra y la Oficina de Capital Estratégico tras los informes de negociaciones con fabricantes de drones estadounidenses https://ml.globenewswire.com/media/76d0c807-d331-4d2f-94f8-1697c3623a8f/small/zenatech-logo-jpg.jpg https://www.haitiscienceandme.com/article/915987407-nordvpn-redefines-digital-protection-with-a-next-generation-antivirus-and-advanced-vpn-in-one-app Haiti, Science, & Me en PressRelease 2026-05-29T13:30:00+00:00 NordVPN redefines digital protection with a next-generation antivirus and advanced VPN in one app https://ml-eu.globenewswire.com/media/f35f4e8f-24e5-42b7-bd7f-d3d17a758a16/small/nord-logo-square-1x-png.png https://www.haitiscienceandme.com/article/915987760-genius-group-provides-response-to-unusual-market-activity Haiti, Science, & Me en PressRelease 2026-05-29T13:15:00+00:00 Genius Group Provides Response to Unusual Market Activity https://ml.globenewswire.com/media/bc7e140d-8c14-43fd-a90e-3337d03946c3/small/logo-png.png https://www.haitiscienceandme.com/article/915987724-the-next-great-ai-revolution-may-be-drug-delivery Haiti, Science, & Me en PressRelease 2026-05-29T13:05:00+00:00 The Next Great AI Revolution May Be Drug Delivery https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://www.haitiscienceandme.com/article/915987718-picogrid-raises-45m-series-a-to-build-the-open-integration-layer-for-modern-defense Haiti, Science, & Me en PressRelease 2026-05-29T13:00:00+00:00 Picogrid Raises $45M Series A to Build the Open Integration Layer for Modern Defense https://ml.globenewswire.com/media/393619fb-0e91-45cb-8394-71546bcfc1ce/medium/picogrid-raises-45m-series-a-to-build-the-open-integration-l.JPG https://www.haitiscienceandme.com/article/915974156-wisekey-s-sealcoin-platform-confirms-integration-of-qait-token-following-market-launch Haiti, Science, & Me en PressRelease 2026-05-29T12:35:28+00:00 WISeKey’s SEALCOIN Platform Confirms Integration of QAIT Token Following Market Launch https://ml-eu.globenewswire.com/media/80dae807-c8a0-4e1a-a0f0-61afcc7ae788/small/wisekey-logo-png.png https://www.haitiscienceandme.com/article/915974533-clearmind-medicine-advances-global-intellectual-property-portfolio-with-japanese-patent-filing-for-innovative-psychedelic-based-depression-treatment Haiti, Science, & Me en PressRelease 2026-05-29T12:32:00+00:00 Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.haitiscienceandme.com/article/915974287-sparrow-pharmaceuticals-to-present-phase-2a-results-for-clofutriben-in-type-2-diabetes-at-the-2026-american-diabetes-association-ada-scientific Haiti, Science, & Me en PressRelease 2026-05-29T12:30:00+00:00 Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session https://ml.globenewswire.com/media/11109705-8086-47a2-af7e-e93ff8d6d5c5/small/sparrow-logo-rgb-2color-horizontal-png.png https://www.haitiscienceandme.com/article/915974380-optimi-health-welcomes-expanded-psychedelic-assisted-therapy-access-under-updated-authorized-prescriber-framework-in-australia Haiti, Science, & Me en PressRelease 2026-05-29T12:30:00+00:00 Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia https://ml.globenewswire.com/media/NDUwMmJkNTYtOTZmMS00ZWJjLTgwZmYtYzhiNWMyMjJmMWM0LTUwMDE2MzM0MC0yMDI2LTA1LTI5LWVu/tiny/OPTIMI-HEALTH-CORP-.png https://www.haitiscienceandme.com/article/915974497-lianhe-sowell-international-group-ltd-announces-results-of-extraordinary-general-meeting-of-shareholders-on-may-29-2026 Haiti, Science, & Me en PressRelease 2026-05-29T12:30:00+00:00 Lianhe Sowell International Group Ltd. Announces Results of Extraordinary General Meeting of Shareholders on May 29, 2026 https://ml.globenewswire.com/media/7ebd443c-dee4-44fc-8b8d-3c1ce0896b8e/small/logo-jpg.jpg https://www.haitiscienceandme.com/article/915974521-imviva-biotech-to-present-data-from-clinical-studies-of-cta313-and-ctd402-validating-its-answer-allogeneic-car-t-platform-in-pediatric-and-adult Haiti, Science, & Me en PressRelease 2026-05-29T12:30:00+00:00 Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses https://ml.globenewswire.com/media/YTViODc1NWQtMTY5My00NDhhLThmMzQtZjIxOTM1NGQyY2JlLTEzMTkxMjUtMjAyNi0wNS0yOS1lbg==/tiny/Imviva-US-Holdings-LLC.png https://www.haitiscienceandme.com/article/915974251-moleculin-presents-asco-2026-data-demonstrating-no-detectable-cardiotoxicity-with-annamycin-despite-exposure-levels-far-exceeding-conventional Haiti, Science, & Me en PressRelease 2026-05-29T12:21:00+00:00 Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.haitiscienceandme.com/article/915974676-saic-board-of-directors-declares-cash-dividend Haiti, Science, & Me en PressRelease 2026-05-29T12:10:00+00:00 SAIC Board of Directors Declares Cash Dividend https://ml.globenewswire.com/media/016c4aa8-2126-4c0d-8d93-9c9291750523/small/saic-logo-rgb-navyblue-lg-jpg.jpg https://www.haitiscienceandme.com/article/915974680-bioxytran-highlights-new-book-on-real-time-monitoring-tissue-oxygenation-relevant-to-oxygen-carrier-bxt-25 Haiti, Science, & Me en PressRelease 2026-05-29T12:03:00+00:00 Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25 https://ml.globenewswire.com/media/383b7569-34f8-4c66-bd5f-996e56457526/small/logo-png.png https://www.haitiscienceandme.com/article/915974526-rail-vision-and-railserve-a-marmon-rail-company-sign-mou-to-expand-collaboration Haiti, Science, & Me en PressRelease 2026-05-29T12:02:00+00:00 Rail Vision and Railserve, a Marmon Rail Company, Sign MOU to Expand Collaboration https://ml.globenewswire.com/media/c6f7afbe-0e17-4b77-9bc3-4e21b6c3ffac/small/railvision-png.png https://www.haitiscienceandme.com/article/915974181-medidata-champions-collaborative-scientific-advancement-at-asco-with-new-research-on-oncology-protocol-optimization-and-car-t-efficacy Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy https://ml.globenewswire.com/media/a26f92c9-b08f-4530-a70f-6dec8dee7e36/small/3ds-medidata-logotype-navy-1-jpg.jpg https://www.haitiscienceandme.com/article/915974188-the-elmet-group-co-reports-first-quarter-2026-results Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 The Elmet Group Co. Reports First Quarter 2026 Results https://ml.globenewswire.com/media/388f5e0b-38dc-47b9-ba7c-d5a0a55a7cc6/small/elmet-jpg.jpg https://www.haitiscienceandme.com/article/915974196-sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-association-s-2026-scientific-sessions-and-focis-2026-annual-meeting Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://www.haitiscienceandme.com/article/915974406-rhythm-pharmaceuticals-announces-seven-abstracts-accepted-for-presentation-at-endo-2026 Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026 https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.haitiscienceandme.com/article/915974412-tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026 Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 https://ml.globenewswire.com/media/95a7de9f-2b24-4ff3-9b57-f8a35e8c049f/small/tenaya-logo-fullcolor-rgb-jpg.jpg https://www.haitiscienceandme.com/article/915974430-tempest-therapeutics-announces-warrant-exercise-for-approximately-2-million-in-gross-proceeds Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.haitiscienceandme.com/article/915974460-replimune-announces-planned-rp1-bla-resubmission-following-productive-discussion-with-fda Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA https://ml.globenewswire.com/media/YjFjNTVkMTUtYWIxNi00ZmU0LWE0ZTctZTQxMTczNTNhZmFjLTExMjIxMDEtMjAyNi0wNS0yOS1lbg==/tiny/Replimune-Inc-.png https://www.haitiscienceandme.com/article/915974475-forewarn-to-provide-identity-verification-services-to-hawaii-realtors-to-promote-agent-safety Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 FOREWARN to Provide Identity Verification Services to Hawaii REALTORS® to Promote Agent Safety https://ml.globenewswire.com/media/e61a6567-c504-4c2e-a2ac-bcfbfcf3a940/small/forewarn-logo-jpg.jpg https://www.haitiscienceandme.com/article/915974495-qtrex-announces-pricing-of-a-10-million-private-placement-of-ordinary-shares-with-a-new-fundamental-institutional-investor Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor https://ml.globenewswire.com/media/418aae9b-ab46-4b61-a649-88b2eef4fc28/small/72a8c93a11446a0369bf7fb191b9562d-png.png https://www.haitiscienceandme.com/article/915974530-jyong-biotech-ceo-outlines-fda-pathway-and-global-strategy-in-pharmaboardroom-live-interview Haiti, Science, & Me en PressRelease 2026-05-29T12:00:00+00:00 Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview https://ml.globenewswire.com/media/a1e08c1c-37e5-4fa0-bc16-0b603810bf0a/small/logo-png.png https://www.haitiscienceandme.com/article/915974515-sagtec-global-limited-acquires-40-strategic-stake-in-malaya-heritage-holding-limited-to-accelerate-f-b-ecosystem-expansion-and-revenue-growth Haiti, Science, & Me en PressRelease 2026-05-29T11:45:00+00:00 Sagtec Global Limited Acquires 40% Strategic Stake in Malaya Heritage Holding Limited to Accelerate F&B Ecosystem Expansion and Revenue Growth https://ml.globenewswire.com/media/5a9f0746-70c9-4fce-ab4c-62d5e8d6a256/medium/strategic-investment-signing-ceremony.jpeg https://www.haitiscienceandme.com/article/915974645-lantronix-announces-pricing-of-30-million-underwritten-offering-of-common-stock Haiti, Science, & Me en PressRelease 2026-05-29T11:32:02+00:00 Lantronix Announces Pricing of $30 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/ba1e6764-b726-4711-9e0c-3b91c6bfbb7e/small/lantronix-logo-with-r-ball-png.png https://www.haitiscienceandme.com/article/915974119-salescloser-reports-second-quarter-fiscal-2026-financial-results-with-significant-year-over-year-revenue-growth Haiti, Science, & Me en PressRelease 2026-05-29T11:30:00+00:00 SalesCloser Reports Second Quarter Fiscal 2026 Financial Results with Significant Year-Over-Year Revenue Growth https://ml-eu.globenewswire.com/media/108434c1-541f-4cd8-b1ed-78394968b9b1/small/screenshot-2026-03-31-at-21-32-17-png.png https://www.haitiscienceandme.com/article/915974469-at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseq-mrd-testing-across-hematology-clinical-practice-and-research Haiti, Science, & Me en PressRelease 2026-05-29T11:30:00+00:00 At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://www.haitiscienceandme.com/article/915974482-zenatech-to-pursue-new-investment-opportunities-connected-with-the-department-of-war-and-office-of-strategic-capital-following-reports-of-engagement Haiti, Science, & Me en PressRelease 2026-05-29T11:30:00+00:00 ZenaTech to Pursue New Investment Opportunities Connected with the Department of War and Office of Strategic Capital Following Reports of Engagement with U.S. Drone Makers https://ml.globenewswire.com/media/76d0c807-d331-4d2f-94f8-1697c3623a8f/small/zenatech-logo-jpg.jpg https://www.haitiscienceandme.com/article/915974512-aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-of-arrangement-with-hanmi-pharmaceutical Haiti, Science, & Me en PressRelease 2026-05-29T11:30:00+00:00 Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg https://www.haitiscienceandme.com/article/915961561-spectral-medical-announces-pma-submission-to-u-s-fda-for-pmx Haiti, Science, & Me en PressRelease 2026-05-29T11:00:00+00:00 Spectral Medical Announces PMA Submission to U.S. FDA for PMX https://ml.globenewswire.com/media/9516c02b-7f3b-41c0-bac1-a037af9a3240/small/new-spectral-logo-rgb-jpg.jpg https://www.haitiscienceandme.com/article/915961576-agios-provides-update-on-phase-2b-trial-of-tebapivat-in-lower-risk-myelodysplastic-syndromes Haiti, Science, & Me en PressRelease 2026-05-29T11:00:00+00:00 Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.haitiscienceandme.com/article/915961605-seer-files-itc-complaint-against-nanomics Haiti, Science, & Me en PressRelease 2026-05-29T11:00:00+00:00 Seer Files ITC Complaint Against Nanomics https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.haitiscienceandme.com/article/915961618-click-holdings-limited-clik-acquires-hong-kong-construction-hr-tech-company-targeting-over-hk-50-million-annual-revenue-in-new-segment-within-two Haiti, Science, & Me en PressRelease 2026-05-29T11:00:00+00:00 Click Holdings Limited (CLIK) Acquires Hong Kong Construction HR Tech Company, Targeting Over HK$50 Million Annual Revenue in New Segment Within Two Years https://ml.globenewswire.com/media/6bb5f0c1-01c8-4634-ac4f-296784dcd2be/small/screenshot-1-jpg.jpg https://www.haitiscienceandme.com/article/915961558-pharvaris-to-present-clinical-data-at-the-eaaci-annual-congress-2026 Haiti, Science, & Me en PressRelease 2026-05-29T10:50:00+00:00 Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.haitiscienceandme.com/article/915947917-ot-group-ltd-announces-strategic-focus-on-digital-infrastructure-investments Haiti, Science, & Me en PressRelease 2026-05-29T09:14:34+00:00 OT Group Ltd Announces Strategic Focus on Digital Infrastructure Investments https://ml.globenewswire.com/media/97b3e9dc-93e5-4f77-9841-09fe3daaba88/medium/ot-group-ltd.jpg https://www.haitiscienceandme.com/article/915947894-sts-digital-joins-global-elite-with-wealthbriefingasia-award Haiti, Science, & Me en PressRelease 2026-05-29T09:00:00+00:00 STS DIGITAL JOINS GLOBAL ELITE WITH WEALTHBRIEFINGASIA AWARD https://ml.globenewswire.com/media/efd6bffc-ad97-4035-8d13-2ac79655b9d5/small/sts-digital-logo-for-sharing-1-png.png https://www.haitiscienceandme.com/article/915935517-auau-technology-announces-global-launch-of-its-market-proven-sports-and-fitness-studio-management-system-saas-to-empower-sports-and-wellness Haiti, Science, & Me en PressRelease 2026-05-29T08:05:00+00:00 AUAU Technology Announces Global Launch of its Market-Proven Sports and Fitness Studio Management System (SaaS) to Empower Sports and Wellness Entrepreneurs https://ml.globenewswire.com/media/b9225364-79dc-4595-95a0-10a7e3be7ab1/medium/auau-technology.jpg https://www.haitiscienceandme.com/article/915935543-further-together-zyt-officially-inaugurates-european-headquarters-launching-multiple-core-business-initiatives Haiti, Science, & Me en PressRelease 2026-05-29T07:41:11+00:00 Further Together: ZYT Officially Inaugurates European Headquarters, Launching Multiple Core Business Initiatives https://ml.globenewswire.com/media/d4a1698d-84c2-483d-a13c-fc656e3bd1e1/medium/image-1-counsellor-wang-hao-attends-and-delivers-a-speech-at.jpeg https://www.haitiscienceandme.com/article/915912923-ec-council-launches-adg-ai-framework-and-self-assessment-tool-to-help-organizations-secure-and-govern-ai-at-scale Haiti, Science, & Me en PressRelease 2026-05-29T05:15:00+00:00 EC-Council Launches ADG AI Framework and Self-Assessment Tool to Help Organizations Secure and Govern AI at Scale  https://ml.globenewswire.com/media/656056b3-d8a1-477e-ba22-c019f650b50f/small/main-logo-png.png https://www.haitiscienceandme.com/article/915912904-wisekey-international-holding-ltd-announces-agenda-items-to-be-approved-by-shareholders-at-its-2026-annual-general-meeting Haiti, Science, & Me en PressRelease 2026-05-29T05:00:00+00:00 WISeKey International Holding Ltd Announces Agenda Items to be Approved by Shareholders at its 2026 Annual General Meeting https://ml-eu.globenewswire.com/media/80dae807-c8a0-4e1a-a0f0-61afcc7ae788/small/wisekey-logo-png.png https://www.haitiscienceandme.com/article/915882499-airjoule-technologies-announces-15-0-million-registered-direct-offering-of-common-stock Haiti, Science, & Me en PressRelease 2026-05-29T02:47:17+00:00 AirJoule Technologies Announces $15.0 Million Registered Direct Offering of Common Stock https://ml.globenewswire.com/media/0dc26aaf-6439-4845-8414-acd9eb675a8a/small/new-logo-fall-2025-airjoule-logo-powertm-liquid-rgb-jpg.jpg